Rijnstate is een algemeen ziekenhuis in midden Gelderland. De hoofdvestiging van het ziekenhuis bevindt zich in Arnhem-Noord. In Velp, Zevenaar en Arnhem-Zuid bevinden zich nevenlocaties. Er werken bijna 4.900 personen, verdeeld over 5 locaties. Het heeft een verzorgingsgebied van circa 450.000 inwoners.

During the past decade, Rijnstate Hospital conducted 227 clinical trials. In the 10-year time frame, 227 clinical trials started and 19 clinical trials were completed, i.e. on average, 8.4% percent of trials that started reached the finish line to date. In the past 5 years, 125 clinical trials started and 13 clinical trials were completed. i.e. 10.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rijnstate Hospital" #1 sponsor was "Rijnstate Hospital" with 80 trials, followed by "Radboud University Medical Center" with 45 trials sponsored, "Erasmus Medical Center" with 12 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 10 trials sponsored and "Amsterdam UMC, location VUmc" with 10 trials sponsored. Other sponsors include 161 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rijnstate Hospital" #1 collaborator was "Rijnstate Hospital" with 29 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 26 trials as a collaborator, "Radboud University Medical Center" with 11 trials as a collaborator, "St. Antonius Hospital" with 10 trials as a collaborator and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 9 trials as a collaborator. Other collaborators include 494 different institutions and companies that were collaborators in the rest 337 trials.

According to Clinical.Site data, the most researched conditions in "Rijnstate Hospital" are "Atrial Fibrillation" (11 trials), "Abdominal Aortic Aneurysm" (10 trials), "Breast Cancer" (9 trials), "Morbid Obesity" (9 trials) and "Obesity" (7 trials). Many other conditions were trialed in "Rijnstate Hospital" in a lesser frequency.

Most popular intervention types in "Rijnstate Hospital" are "Drug" (123 trials), "Other" (55 trials), "Device" (53 trials), "Procedure" (46 trials) and "Diagnostic Test" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Apixaban" (5 trials), "Carboplatin" (4 trials), "Fulvestrant" (3 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Rijnstate Hospital" are 279 trials for "All" genders, 28 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are 137 active trials in "Rijnstate Hospital". 6 are not yet recruiting, 93 are recruiting, 32 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 120 completed trials in Rijnstate Hospital, 1 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Rijnstate Hospital, 5 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 109 trials that are defined as “Not Applicable".